Guidance through
every phase
Candidate selection
KLIFO helps you navigate this transition with precision and senior-level guidance, turning potential into development-ready assets.
Drug development strategy:
KLIFO’s senior consultants align preclinical, clinical, CMC and regulatory plans into one coherent roadmap, keeping your development on track from early planning to successful approval.
Phase I trial:
KLIFO’s specialists have decades of hands-on experience running phase 1 trials across multiple therapeutic areas. Unlike one-size-fits-all CROs, we combine senior expertise with lean, pragmatic project structures.
Phase II trial:
KLIFO brings more than operational capability — we bring the strategic depth needed to navigate Phase 2, where promising compounds often fail.
Phase III trial:
KLIFO’s specialists bring extensive experience from managing large, international phase 3 programmes.
Regulatory filing:
At KLIFO, we support pharma and biotech companies in planning, preparing and submitting regulatory filings.
Phase IV trial:
KLIFO brings the strategic and operational expertise needed to navigate phase 4.
Life cycle management:
At KLIFO, we partner with companies to maintain regulatory approvals, optimise product value and support global expansion through every post-approval activity.
Veeva Vault
KLIFO offers a managed Veeva Vault for EDMS and eTMF: secure, compliant, plug & play document management tailored for biotech, with no implementation project required.